Want to join the conversation?
Consumer Edge Research analyst Brian Holland asks if Dave's and Alpine brands performed in line with plan in 2Q16. $FLO says that Dave's is doing really well in line with plan, while Alpine was a little behind from what was projected as Warehouse distribution, some of the new business, as well as space authorizations were slower coming on Alpine.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.